Recognition and management of complications during transcatheter aortic valve implantation

References

• Grube E, Schuler G, Buellesfeld L et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol.50, 69–76 (2007).
   PubMed Web of Science ®Google Scholar
• Webb JG, Pasupati S, Humphries K et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation116(7), 755–763 (2007).
   PubMed Web of Science ®Google Scholar
• Thomas M, Schymik G, Walther T et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation122, 62–69 (2010).
   PubMed Web of Science ®Google Scholar
• Piazza N, Grube E, Gerckens U et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention4(2), 242–249 (2008).
   PubMedGoogle Scholar
• Zahn R, Gerckens U, Grube E et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J.32(2), 198–204 (2011).
   PubMed Web of Science ®Google Scholar
• Eltchaninoff H, Prat A, Gilard M et al. Transcatheter aortic valve implantation: early results of the FRANCE (French Aortic National CoreValve and Edwards) registry. Eur. Heart J.32(2), 191–197 (2011).
   PubMed Web of Science ®Google Scholar
• Tamburino C, Capodanno D, Ramondo A et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation123, 299–308 (2011).
   PubMed Web of Science ®Google Scholar
• Bosmans JM, Kefer J, De Bruyne B et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact. Cardiovasc. Thorac. Surg.12, 762–767 (2011).
   PubMed Web of Science ®Google Scholar
• Khawaja MZ, Rajani R, Cook A et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation123(9), 951–960 (2011).
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack M et al.; for the PARTNER trial investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med.363, 1597–1607 (2010).
   PubMed Web of Science ®Google Scholar
• Buellesfeld L, Gerckens U, Schuler G et al. 2-Year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J. Am. Coll. Cardiol.57, 1650–1657 (2011).
   PubMed Web of Science ®Google Scholar
• Lichtenstein SV, Cheung A, Ye J et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation114(6), 591–596 (2006).
   PubMed Web of Science ®Google Scholar
• Webb JG, Chandavimol M, Thompson CR et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation113(6), 842–850 (2006).
   PubMed Web of Science ®Google Scholar
• Grube E, Laborde JC, Gerckens U et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation114(15), 1616–1624 (2006).
   PubMed Web of Science ®Google Scholar
• Bagur R, Rodés-Cabau J, Doyle D. Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation. JACC Cardiovasc. Imaging4(2), 115–124 (2011).
   Web of Science ®Google Scholar
• Van Mieghem NM, Nuis R, Piazza N et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System®: the Rotterdam experience. EuroIntervention5, 673–679 (2010).
   PubMed Web of Science ®Google Scholar
• Kahlert P, Al-Rashid F, Weber M et al. Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz34, 398–408 (2009).
   Google Scholar
• Ducrocq D, Francis F, Serfaty JM et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention5, 666–672 (2010).
   PubMed Web of Science ®Google Scholar
• Tchetche D, Dumonteil N, Sauget A et al. 30 day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprosthesis in a mixed population. EuroIntervention5, 659–665 (2010).
   PubMed Web of Science ®Google Scholar
• Webb JG, Altwegg L, Boone RH et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation119, 3009–3016 (2009).
   PubMed Web of Science ®Google Scholar
• Leon MB, Piazza N, Nikolsky E et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J. Am. Coll. Cardiol.57(3), 253–269 (2011).
   PubMed Web of Science ®Google Scholar
• Eggebrecht H, Kahlert P, Thielmann M, Plicht B, Erbel R. Usefulness of a novel balloon-expandable vascular sheath for facilitated large-bore arterial access for transcatheter aortic valve implantation. EuroIntervention6, 893–894 (2011).
   Google Scholar
• Sharp ASP, Michev I, Maisano F et al. A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc. Interv.75, 784–793 (2010).
   PubMed Web of Science ®Google Scholar
• Masson J, Kovac J, Schuler G et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. J. Am. Coll. Cardiol.2, 811–820 (2009).
   Web of Science ®Google Scholar
• Al Ali AM, Altwegg L, Horlick EM et al. Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc. Interv.72, 573–578 (2008).
   PubMedGoogle Scholar
• Geisbüsch S, Bleiziffer S, Mazzitelli D et al. Incidence and management of corevalve dislocation during transcatheter aortic valve implantation. Circ. Cardiovasc. Interv.3, 531–536 (2010).
   Google Scholar
• Tops LF, Krishnan SC, Schuijf JD, Schalij MJ, Bax JJ. Noncoronary applications of cardiac multi-detector row computed tomography. JACC Cardiovasc. Imaging1, 94–106 (2008).
   Google Scholar
• Rivard AL, Bartel T, Bianco RW et al. Evaluation of aortic root and valve calcifications by multi-detector computed tomography. J. Heart Valve Dis.18, 662–670 (2009).
   Google Scholar
• Geist V, Sherif MA, Khattib AA. Successful percutaneous coronary intervention after implantation of a CoreValve percutaneous aortic valve. Catheter Cardiovasc. Interv.73, 61–67 (2009).
   Google Scholar
• Stabile E, Sorropago G, Cioppa A et al. Acute left main obstructions following TAVI. EuroIntervention6, 100–105 (2010).
   Google Scholar
• Gogas BD, Zacharoulis AA, Antoniadis AG. Acute coronary occlusion following TAVI. Catheter Cardiovasc. Interv.77(3), 435–438 (2011).
   Google Scholar
• Webb JG. Coronary obstruction due to transcatheter valve implantation Catheter Cardiovasc. Interv.73, 973 (2009).
   PubMed Web of Science ®Google Scholar
• Wong DR, Boone RH, Thompson CR et al. Mitral valve injury late after transcatheter aortic valve implantation. J. Thorac. Cardiovasc. Surg.137, 1547–1549 (2009).
   PubMedGoogle Scholar
• Comoglio C, Boffini M, El Qarra S et al. Aortic valve replacement and mitral valve repair as treatment of complications after percutaneous CoreValve implantation. J. Thorac. Cardiovasc. Surg.138, 1025–1027 (2009).
   PubMedGoogle Scholar
• Ong SH, Mueller R, Gerckens U. Iatrogenic dissection of the ascending aorta during TAVI sealed with the corevalve revalving prosthesis. Catheter Cardiovasc. Interv.77(6), 910–914 (2011).
   Google Scholar
• Abdel-Wahab M, Zahn R, Horack M et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart97(11), 899–906 (2011).
   PubMed Web of Science ®Google Scholar
• Gerckens U, Latsios G, Mueller R et al. Procedural and mid-term results in patients with aortic stenosis treated with implantation of 2 (in-series) CoreValve prostheses in 1 procedure. JACC Cardiovasc. Interv.3(2), 244–250 (2010).
   PubMed Web of Science ®Google Scholar
• El-Khally Z, Thibault B, Staniloae C et al. Prognostic significance of newly acquired bundle branch block after aortic valve replacement. Am. J. Cardiol.94, 1008–1011 (2004).
   Google Scholar
• Limongelli G, Ducceschi V, D’Andrea A et al. Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience. Heart89(8), 901–904 (2003).
   Google Scholar
• Sinhal A, Altwegg L, Pasupati S et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc. Interv.1(3), 305–309 (2008).
   Web of Science ®Google Scholar
• Piazza N, Onuma Y, Jesserun E et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc. Interv.1, 310–316 (2008).
   PubMed Web of Science ®Google Scholar
• Khawaja MZ, Rajani R, Cook A et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation123(9), 951–960 (2011).
   PubMed Web of Science ®Google Scholar
• Kahlert P, Knipp SC, Schlamann M et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation121, 870–878 (2010).
   PubMed Web of Science ®Google Scholar
• Cribier A, Eltchaninoff H, Tron C et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol.47, 1214–1223 (2006).
   PubMed Web of Science ®Google Scholar
• Grube E, Buellesfeld L, Mueller R et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ. Cardiovasc. Interv.1(3), 167–175 (2008).
   PubMed Web of Science ®Google Scholar
• Svensson LG, Dewey T, Kapadia S et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann. Thorac Surg.86, 46–54 (2008).
   Web of Science ®Google Scholar
• Nietlispach F, Wijesinghe N, Gurvitch R et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc. Interv.3(11), 1133–1138 (2010).
   PubMed Web of Science ®Google Scholar
• Piazza N, Schultz C, de Jaegere PP, Serruys PW. Implantation of two self-expanding aortic bioprosthetic valves during the same procedure? Insights into valve-in-valve implantation (‘Russian doll concept’). Catheter Cardiovasc. Interv.73, 530–539 (2009).
   PubMed Web of Science ®Google Scholar
• Sinning J, Ghanem A, Steinhäuser H et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc. Interv.3, 1141–1149 (2010).
   PubMed Web of Science ®Google Scholar
• Aregger F, Wenaweser P, Hellige GJ et al. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement Nephrol. Dial. Transplant.24, 2175–2179 (2009).
   PubMed Web of Science ®Google Scholar
• Sherif MA, Abdel-Wahab M, Stöcker B et al. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the medtronic corevalve bioprosthesis. J. Am. Coll. Cardiol.56, 1623–1629 (2010).
   PubMed Web of Science ®Google Scholar
• Détaint D, Lepage L, Himbert D et al. Determinants of significant paravalvular regurgitation after transcatheter aortic valve implantation impact of device and annulus discongruence. J. Am. Coll. Cardiol. Intv.2, 821–827 (2009).
   Google Scholar